The effects of glucose-dependent insulinotropic polypeptide on net splanchnic blood flow in lean humans.
rct · Level II
Where this comes from
- Record sourced from PubMed, PMID 41782271.
- Also identified by DOI 10.1210/clinem/dgag084.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The aim of this study was to examine the effects of glucose-dependent insulinotropic polypeptide (GIP) on splanchnic blood flow, both independently and in combination with hyperglycemia and hyperinsulinemia. In a randomized, placebo-controlled, crossover trial, eight healthy, lean male participants underwent four separate experimental conditions. Splanchnic blood flow was measured by Fick's Principle after catheterization of a hepatic vein, using indocyanine green as indicator. The interventions included intravenous infusions of either GIP at a rate of 1.5 pmol/kg/min or saline, administered alone or in combination with a hyperglycemia and hyperinsulinemia clamp, respectively. Splanchnic blood flow remained comparable across all experimental conditions, including GIP and saline infusions, both with and without the hyperglycemic and hyperinsulinemic clamp (P=0.42). Under the applied conditions, GIP does not appear to play a substantial role in the acute regulation of net splanchnic blood flow, either alone or in combination with induced hyperglycemia and hyperinsulinemia.